BioHarvest Sciences Inc. (BHST) Q2 2025 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST ) Q2 2025 Earnings Conference Call August 11, 2025 8:00 AM ET Company Participants Bar Dichter - Chief Financial Officer Ilan Sobel - Chief Executive Officer Conference Call Participants Amit Dayal - H.C. Wainwright & Co, LLC, Research Division Anthony V.
BioHarvest Sciences Q2 revenue jumps on VINIA growth
BioHarvest Sciences Inc. (NASDAQ:BHST) reported a 41% rise in second-quarter revenue, driven by growth in its VINIA product line and contributions from its contract development and manufacturing (CDMO) business. Revenue for the quarter ended June 30 rose to $8.5 million from $6 million a year earlier, in line with the company's guidance.
BioHarvest Sciences Inc. (BHST) Surges 5.6%: Is This an Indication of Further Gains?
BioHarvest Sciences Inc. (BHST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BioHarvest Sciences launches Informed Sport-certified daily chew - ICYMI
BioHarvest Sciences Inc. (NASDAQ:BHST) CEO Ilan Sobel talked with Proactive about the company's newest addition to its Vinia product line, a daily “2X formula” chew, specifically designed for athletes and highly active consumers. The chew delivers 12mg of Piceid Resveratrol, doubling the dose found in the original capsule format.
BioHarvest Sciences launches Informed Sport-certified VINIA DailyChews 2X Formula
BioHarvest Sciences Inc. (NASDAQ:BHST) has launched a new product tailored to athletes and individuals with active lifestyles called VINIA DailyChews 2X Formula. The developer of botanical-based wellness products using its proprietary Botanical Synthesis said this new product is now available for purchase in a 30-count pack through VINIA.com.
What Makes BioHarvest Sciences Inc. (BHST) a Good Fit for 'Trend Investing'
BioHarvest Sciences Inc. (BHST) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
BioHarvest enters fragrance industry with AI edge - ICYMI
BioHarvest Sciences Inc. (NASDAQ:BHST) earlier this week announced a new contract targeting the plant-based fragrance compound market, using its proprietary botanical synthesis platform. CEO Ilan Sobel said the contract focuses on a rare plant under threat from overharvesting and habitat loss.
BioHarvest inks fragrance compound deal in move into multi-billion-dollar scents market
BioHarvest Sciences Inc. (NASDAQ:BHST) said it has signed a contract to develop a plant-based fragrance compound using its patented Botanical Synthesis technology, marking the company's entry into the multi-billion-dollar fragrance and scents industry. The contract, with an undisclosed commercial partner, targets the development of a compound derived from a threatened plant species facing overharvesting and habitat loss.
BioHarvest Sciences Inc. (BHST) Q1 2025 Earnings Call Transcript
BioHarvest Sciences Inc. (NASDAQ:BHST ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Ilan Sobel - CEO Bar Dichter - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Amit Dayal - H.C. Wainwright Susan Anderson - Canaccord Genuity Nicholas Sherwood - Maxim Group Hunter Diamond - Diamond Equity Research Operator Greetings, and welcome to the BioHarvest Sciences First Quarter 2025 Corporate Update Conference Call.
BioHarvest Sciences Inc. (BHST) Reports Q1 Loss, Tops Revenue Estimates
BioHarvest Sciences Inc. (BHST) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago.
BioHarvest Sciences Q1 revenue jumps on VINIA growth
BioHarvest Sciences Inc. (NASDAQ:BHST), a developer of plant-based biologics, reported a 47% year-over-year jump in first-quarter revenue on Wednesday, driven by strong demand for its flagship VINIA line of wellness products. Revenue for the quarter ended March 31 rose to $7.9 million, topping internal forecasts, as gross margins expanded by 227 basis points to 58.5%.
BioHarvest Sciences Inc. (BHST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
BioHarvest Sciences Inc. (BHST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
